Top Health Care Stocks <\/p>\n
JNJ -0.55% <\/p>\n
PFE +0.26% <\/p>\n
ABT -0.18% <\/p>\n
MRK -0.57% <\/p>\n
AMGN -2.81% <\/p>\n
Health care stocks were mostly lower, with the NYSE Health Care Sector Index retreating about 0.7% and shares of health care companies in the S&P 500 down about 0.6% as a group. <\/p>\n
In company news, Advaxis Inc. ( ADXS ) was higher Monday after federal regulators cleared the biotech company to begin Phase I\/II testing early next year of its ADXS-HPV anti-cancer therapy either alone or in combination with AstraZeneca's ( AZN ) MEDI4736 drug candidate. <\/p>\n
ADXS shares were up 15% at $4.35 apiece, just 4 cents off their session high. The stock has traded within a 52-week range of $2.46 to $5.99 a share, declining almost 12% over the past year prior to Monday's advance. <\/p>\n
Approval of ADXS' Investigational New Drug application by the U.S. Food and Drug Administration allows the company to proceed with a trial to evaluate ADXS-HPV as a prospective treatment for advanced, recurrent or refractory human papillomavirus-associated cervical cancer and HPV-associated head and neck cancer. <\/p>\n
<\/p>\n
Go here to read the rest:<\/p>\n
Health Care Sector Update for 12\/15\/2014: ADXS, AZN, OPK, SHS, PFE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Top Health Care Stocks JNJ -0.55% PFE +0.26% ABT -0.18% MRK -0.57% AMGN -2.81% Health care stocks were mostly lower, with the NYSE Health Care Sector Index retreating about 0.7% and shares of health care companies in the S&P 500 down about 0.6% as a group. In company news, Advaxis Inc Continue reading